VX-950-C211 – A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
Condition(s):Genotype 1 Chronic Hepatitis C; Treatment NaiveLast Updated:June 4, 2014Completed